- Home
- SNY vs PLD Comparison
SNY vs PLD Comparison
Compare SNY & PLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- PLD
- Stock Information
- Founded
- SNY 1994
- PLD 1983
- Country
- SNY France
- PLD United States
- Employees
- SNY N/A
- PLD N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- PLD Real Estate Investment Trusts
- Sector
- SNY Health Care
- PLD Real Estate
- Exchange
- SNY Nasdaq
- PLD Nasdaq
- Market Cap
- SNY 116.5B
- PLD 100.2B
- IPO Year
- SNY N/A
- PLD 1994
- Fundamental
- Price
- SNY $48.61
- PLD $109.09
- Analyst Decision
- SNY Buy
- PLD Buy
- Analyst Count
- SNY 2
- PLD 19
- Target Price
- SNY $62.50
- PLD $120.82
- AVG Volume (30 Days)
- SNY 2.2M
- PLD 4.1M
- Earning Date
- SNY 07-31-2025
- PLD 07-16-2025
- Dividend Yield
- SNY 3.29%
- PLD 3.70%
- EPS Growth
- SNY 39.56
- PLD 17.35
- EPS
- SNY 5.45
- PLD 4.01
- Revenue
- SNY $48,817,552,946.00
- PLD $8,733,704,000.00
- Revenue This Year
- SNY $3.39
- PLD $0.21
- Revenue Next Year
- SNY $7.05
- PLD $5.95
- P/E Ratio
- SNY $8.92
- PLD $27.22
- Revenue Growth
- SNY N/A
- PLD 2.56
- 52 Week Low
- SNY $45.80
- PLD $85.35
- 52 Week High
- SNY $60.12
- PLD $132.57
- Technical
- Relative Strength Index (RSI)
- SNY 46.26
- PLD 56.67
- Support Level
- SNY $47.99
- PLD $105.28
- Resistance Level
- SNY $49.43
- PLD $110.00
- Average True Range (ATR)
- SNY 0.58
- PLD 2.56
- MACD
- SNY 0.18
- PLD 0.24
- Stochastic Oscillator
- SNY 56.15
- PLD 82.44
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
About PLD Prologis Inc.
Prologis was formed by the June 2011 merger of AMB Property and Prologis Trust. The company develops, acquires, and operates around 1.3 billion square feet of high-quality industrial and logistics facilities across the globe. The company also has a strategic capital business segment that has around $60 billion of third-party AUM. The company is organized into four global divisions (Americas, Europe, Asia, and other Americas) and operates as a real estate investment trust.